SCHEMBL5553290

SCHEMBL5553290

CCCC1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propanol SCHEMBL1011878 0.89 FYN (0.39)
SCHEMBL8461435 0.88
SCHEMBL20429701 0.83 FYN (0.31)
SCHEMBL10825613 0.82
SCHEMBL28103103 0.81
SCHEMBL10697801 0.80
SCHEMBL11442542 0.79
SCHEMBL11727901 0.78 ALDH1A1 (0.56)
Methyl Alcohol SCHEMBL22499764 0.78 CYP1A2 (0.46)
SCHEMBL11691475 0.78 ALDH1A1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106232590-A There is the preparation of 2 substituted 4 hydroxyl 4 methyl Pentamethylene oxide .s of stable aroma quality 巴斯夫欧洲公司 2016-12-14 CN claimed
CN-106170483-A 2 replacement 4 hydroxyl 4 methyl Pentamethylene oxide .s are prepared by the raw material comprising 2 alkyl 4,4 dimethyl 1,3 dioxanes 巴斯夫欧洲公司 2016-11-30 CN claimed
US-12037357-B2 Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells DECIDUOUS THERAPEUTICS, INC. (US) 2024-07-16 US disclosed
US-20240093027-A1 POLYMERS USEFUL AS SURFACE LEVELING AGENTS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-03-21 US disclosed
US-11912668-B2 GCN2 and perk kinase inhibitors and methods of use thereof DECIPHERA PHARMACEUTICALS, LLC (US) 2024-02-27 US disclosed
US-20240025936-A1 COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS DECIDUOUS THERAPEUTICS, INC. (US) 2024-01-25 US disclosed
US-11859082-B2 Polymers useful as surface leveling agents ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2024-01-02 US disclosed
EP-3983385-B1 NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS PTC THERAPEUTICS INC (US) 2023-08-30 EP disclosed
US-20220395576-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2022-12-15 US disclosed
CN-113264856-B Sulfonium salt, photoacid generator, and photosensitive composition 东京应化工业株式会社 2022-11-22 CN disclosed
CN-114685775-A Polymers useful as surface leveling agents, methods of making the same, and articles comprising the same 罗门哈斯电子材料有限责任公司 2022-07-01 CN disclosed
US-20150105252-A1 SUBSTITUTED PYRAZOLES AS HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY 2015-04-16 US disclosed
WO-2015007693-A1 METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-01-22 WO disclosed
EP-2826779-A1 Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-01-21 EP disclosed
US-20140288141-A1 PRMT1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 US disclosed
US-20140288105-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 US disclosed
US-20140057916-A1 SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-27 US disclosed
US-20120208819-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS OXFORD FINANCE LLC, AS COLLATERAL AGENT 2012-08-16 US disclosed
EP-1812421-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-08-01 EP disclosed
WO-2006055922-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-05-26 WO disclosed